Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
9.40
-0.98 (-9.44%)
Nov 2, 2026, 2:05 PM EST - Market open
GOSS's stock price has decreased by -95.13% in the past year and price targets may not have had time to catch up.
Gossamer Bio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Buy Initiates $160 | Buy | Initiates | $160 | +1,602.13% | Oct 13, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $90 | Buy | Reiterates | $90 | +857.45% | Sep 21, 2026 |
| Wedbush | Wedbush | Hold Maintains $80 | Hold | Maintains | $80 | +751.06% | Aug 14, 2026 |
| Barclays | Barclays | Sell Maintains $22 | Sell | Maintains | $22 | +138.30% | Jul 28, 2026 |
| Leerink Partners | Leerink Partners | Buy Upgrades $80 | Buy | Upgrades | $80 | +751.06% | Jul 27, 2026 |